ArticleCancer science2014

Interleukin 6 augments lung cancer chemotherapeutic resistance via ataxia-telangiectasia mutated/NF-kappaB pathway activation.

Hong Qiong Yan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.